200 related articles for article (PubMed ID: 27558696)
1. Lipid composition of circulating multiple-modified low density lipoprotein.
Zakiev ER; Sukhorukov VN; Melnichenko AA; Sobenin IA; Ivanova EA; Orekhov AN
Lipids Health Dis; 2016 Aug; 15(1):134. PubMed ID: 27558696
[TBL] [Abstract][Full Text] [Related]
2. Carbohydrate composition of circulating multiple-modified low-density lipoprotein.
Zakiev ER; Sobenin IA; Sukhorukov VN; Myasoedova VA; Ivanova EA; Orekhov AN
Vasc Health Risk Manag; 2016; 12():379-385. PubMed ID: 27789955
[TBL] [Abstract][Full Text] [Related]
3. Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization.
Tertov VV; Sobenin IA; Gabbasov ZA; Popov EG; Jaakkola O; Solakivi T; Nikkari T; Smirnov VN; Orekhov AN
Lab Invest; 1992 Nov; 67(5):665-75. PubMed ID: 1434544
[TBL] [Abstract][Full Text] [Related]
4. Naturally occurring modified low density lipoproteins are similar if not identical: more electronegative and desialylated lipoprotein subfractions.
Tertov VV; Bittolo-Bon G; Sobenin IA; Cazzolato G; Orekhov AN; Avogaro P
Exp Mol Pathol; 1995 Jun; 62(3):166-72. PubMed ID: 8612720
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of low density lipoprotein isolated from circulating immune complexes.
Tertov VV; Sobenin IA; Orekhov AN; Jaakkola O; Solakivi T; Nikkari T
Atherosclerosis; 1996 May; 122(2):191-9. PubMed ID: 8769682
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Apolipoprotein B Protein of Circulating Multiple-Modified Low-Density Lipoprotein.
Zakiev ER; Sukhorukov VN; Ivanova EA; Orekhov AN
Int J Angiol; 2017 Mar; 26(1):49-52. PubMed ID: 28255216
[TBL] [Abstract][Full Text] [Related]
7. Antioxidant content in low density lipoprotein and lipoprotein oxidation in vivo and in vitro.
Tertov VV; Sobenin IA; Kaplun VV; Orekhov AN
Free Radic Res; 1998 Aug; 29(2):165-73. PubMed ID: 9790519
[TBL] [Abstract][Full Text] [Related]
8. Characterization of desialylated low-density lipoproteins which cause intracellular lipid accumulation.
Tertov VV; Sobenin IA; Orekhov AN
Int J Tissue React; 1992; 14(4):155-62. PubMed ID: 1478792
[TBL] [Abstract][Full Text] [Related]
9. Characterization of chemical composition of native and modified low density lipoprotein occurring in the blood of diabetic patients.
Sobenin IA; Tertov VV; Orekhov AN
Int Angiol; 1994 Mar; 13(1):78-83. PubMed ID: 8077803
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein B-bound lipids as a marker for evaluation of low density lipoprotein oxidation in vivo.
Tertov VV; Kaplun VV; Dvoryantsev SN; Orekhov AN
Biochem Biophys Res Commun; 1995 Sep; 214(2):608-13. PubMed ID: 7677772
[TBL] [Abstract][Full Text] [Related]
11. Low-density lipoprotein modification occurring in human plasma possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification.
Tertov VV; Kaplun VV; Sobenin IA; Orekhov AN
Atherosclerosis; 1998 May; 138(1):183-95. PubMed ID: 9678784
[TBL] [Abstract][Full Text] [Related]
12. [Carbohydrate composition of native and desialylated low density lipoproteins in the plasma of patients with coronary atherosclerosis].
Tertov VV; Sobenin IA; Gevara Kh; Morrisett DD; Orekhov AN
Kardiologiia; 1992 Sep; 32(9-10):57-61. PubMed ID: 1287315
[TBL] [Abstract][Full Text] [Related]
13. [Desialylated low density lipoproteins--atherogenic lipoproteins occurring in blood of patients with coronary atherosclerosis].
Mukhin DN; Tertov VV; Kacharava AG; Orekhov AN
Biull Eksp Biol Med; 1990 Aug; 110(8):138-40. PubMed ID: 2291955
[TBL] [Abstract][Full Text] [Related]
14. Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells: discovery of desialylated lipoprotein with altered cellular metabolism in the blood of atherosclerotic patients.
Orekhov AN; Tertov VV; Mukhin DN; Mikhailenko IA
Biochem Biophys Res Commun; 1989 Jul; 162(1):206-11. PubMed ID: 2751649
[TBL] [Abstract][Full Text] [Related]
15. Lipidomic analysis of plasma lipoprotein fractions in myocardial infarction-prone rabbits.
Takeda H; Koike T; Izumi Y; Yamada T; Yoshida M; Shiomi M; Fukusaki E; Bamba T
J Biosci Bioeng; 2015 Oct; 120(4):476-82. PubMed ID: 26162515
[TBL] [Abstract][Full Text] [Related]
16. Modified low density lipoprotein from diabetic patients causes cholesterol accumulation in human intimal aortic cells.
Sobenin IA; Tertov VV; Koschinsky T; Bünting CE; Slavina ES; Dedov II; Orekhov AN
Atherosclerosis; 1993 Apr; 100(1):41-54. PubMed ID: 8318062
[TBL] [Abstract][Full Text] [Related]
17. Desialylated low density lipoprotein--naturally occurring modified lipoprotein with atherogenic potency.
Orekhov AN; Tertov VV; Mukhin DN
Atherosclerosis; 1991 Feb; 86(2-3):153-61. PubMed ID: 1872910
[TBL] [Abstract][Full Text] [Related]
18. [Atherogenic modification of low-density lipoproteins].
Sukhorukov VN; Karagodin VP; Orekhov AN
Biomed Khim; 2016 May; 62(4):391-402. PubMed ID: 27562992
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of low-density lipoprotein subfractions from patients with coronary artery disease.
Jaakkola O; Solakivi T; Tertov VV; Orekhov AN; Miettinen TA; Nikkari T
Coron Artery Dis; 1993 Apr; 4(4):379-85. PubMed ID: 8261211
[TBL] [Abstract][Full Text] [Related]
20. Hypoalbuminemia increases lysophosphatidylcholine in low-density lipoprotein of normocholesterolemic subjects.
Vuong TD; Stroes ES; Willekes-Koolschijn N; Rabelink TJ; Koomans HA; Joles JA
Kidney Int; 1999 Mar; 55(3):1005-10. PubMed ID: 10027937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
